What is Pison?
Founded in 2016, Pison Technology operates at the intersection of neuroscience and digital engineering. The company specializes in capturing and interpreting biopotential signals, effectively translating complex neurological data into actionable insights. By developing a robust platform that supports high-fidelity data analysis, Pison is carving out a unique market position as a critical infrastructure provider for next-generation health and performance monitoring. Their technology serves as a foundational layer for developers and researchers aiming to unlock new capabilities in the physical and digital realms, moving beyond traditional input methods to leverage the inherent power of human neural activity.
How much funding has Pison raised?
Pison has raised a total of $7M across 1 funding round:
Series A
$7M
Series A (2021): $7M with participation from Lavrock Ventures LLC
Key Investors in Pison
Lavrock Ventures LLC
A venture capital firm focused on early-stage investments in software and technology companies that solve complex problems for the government and commercial sectors.
What's next for Pison?
With the successful closure of this Series A financing, Pison is entering a critical phase of commercial expansion and product refinement. The strategic allocation of this capital will likely focus on deepening the integration of their biopotential platform within medical diagnostic workflows and expanding their footprint in the sports performance analytics market. As the company matures, the focus will shift toward scaling its software-as-a-service capabilities and fostering partnerships with hardware manufacturers to embed Pison technology into wearable devices. This trajectory suggests a long-term goal of establishing a universal standard for neural-based digital interaction, positioning the firm as a key player in the evolving landscape of human-centric technology.
See full Pison company page
